Patents
Sitemap › C07 - Organic chemistry › C07K - Peptides › C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
Patents for C07K 14 - Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof (291,526)
12/2005
12/22/2005US20050282740 Methods and compositions for regulating protein-protein interactions
12/22/2005US20050282737 Procollagen (III) propeptides and related substances for treating fibrotic diseases
12/22/2005US20050282729 Cysteine-rich secretory protein (CRISP); CRISP polypeptide inhibits tyrosine phosphorylation of sperm proteins; inhibiting sperm fertilizing-ability without affecting the hormonal balance in male or females
12/22/2005US20050282278 Plant sugar transport proteins
12/22/2005US20050282277 Methods of increasing platelet and hematopoietic stem cell production
12/22/2005US20050282259 Nucleotide sequences for encoding of the lysR2-gene
12/22/2005US20050282258 Using transgenic escherichia as bioreactor for alanine production for use in processed food industry, animal feeds and human parenteral nutrition supplements
12/22/2005US20050282256 Adipocyte complement related protein zacrp13
12/22/2005US20050282255 Cell growth differentiation factor (MP52) for use in treatment and prevention of nervous system, dental, skin, connective tissue and bone disorders; wound healing agents
12/22/2005US20050282254 Optimized recognition site of the alphavirus non-structural protease for tag removal and specific processing of recombinant proteins
12/22/2005US20050282253 Inhibit endothelial cell proliferation, angiogenesis and cause tumor regression; antiproliferative, anticarcinogenic and antitumor agents
12/22/2005US20050282247 Recombinant single chain antibody in heterotrophic algae for pathogen control and use
12/22/2005US20050282239 Cell-permeable enzyme activation reporter that can be loaded in a high throughput and gentle manner
12/22/2005US20050282230 Method for making monoclonal antibodies and cross-reactive antibodies obtainable by the method
12/22/2005US20050282222 Nematode PAN and ZP receptor-like sequences
12/22/2005US20050282217 Using TR10 polypeptide, which is a member of the tumor necrosis factor (TNF) receptor superfamily for inhibiting apoptosis associated with HIV infection
12/22/2005US20050282216 Purified polypeptides having IL-13 receptor activity
12/22/2005US20050282215 Isolated cytokine receptor LICR-2
12/22/2005US20050282191 Antibody or fragment that binds immunospecifically to a polypeptide; diagnosing and treatment of testicular cancer; spermatid-specific thioredoxin-3 (Sptrx-3) enzyme is used as a fertility marker; biodrugs
12/22/2005US20050282187 Reagents and methods useful for detecting diseases of the urinary tract
12/22/2005US20050282183 Methods and compositions for pearl oyster cultivation
12/22/2005US20050282178 Novel human gene with immunoregulatory and anti-proliferative properties
12/22/2005US20050282167 Methods and compositions for regulating adipogenesis
12/22/2005US20050282166 Method for the expression of unknown environmental dna into adapted host cells
12/22/2005US20050282160 Allowing a transporter protein, whose function cannot be identified because of the inability to be transferred to a cell membrane in an exogenous gene expression system, to be transferred to the cell membrane by forming a fusion protein with a protein that promotes the transfer.
12/22/2005US20050282157 Using oligonucleotide and peptide nucleic acid oligomers for use as diagnostic tool in monitoring cytosine methylation; detecting cell proliferative, inflammatory, connective, bone, nervous system and cardiovascular disorders
12/22/2005US20050282154 Angiotensin-converting enzyme-2 as a receptor for the SARS coronavirus
12/22/2005US20050282150 Identifying an inhibitor of cyclin E2 polypeptide/cyclic-dependent kinase-2 complex formation by allowing a cyclin E2 polypeptide having a specific sequence and cdk2 to spontaneously associate to form a cyclin E2 polypeptide/cdk2 complex; adding test compound; and assaying for a decrease in complex
12/22/2005US20050281847 Vaccine composition
12/22/2005US20050281845 Hapten-carrier conjugates and uses thereof
12/22/2005US20050281844 Immunization for Ebola virus infection
12/22/2005US20050281837 Immunologically active peptides with altered toxicity useful for the preparation of antipertussis vaccine
12/22/2005US20050281836 Synthetic vaccine for tick control
12/22/2005US20050281835 Polypeptide and polynucleotide of given sequences; monoclonal antibody binding to antigen Ag473; use in vaccines and diagnosis
12/22/2005US20050281831 inhibiting vascularization or angiogenesis using chimeric proteins, immunoglobulin-like domains of tyrosine kinase receptors
12/22/2005US20050281829 Fc chimeric proteins with anti-HIV drugs
12/22/2005US20050281827 Trypanosome derived apoptotic factors (TAF)
12/22/2005US20050281824 Methods of using IMXP-888 and IMXP-888 antagonists
12/22/2005US20050281816 vaccines; treatment of allergies; three modules: a translocation module to transport MAT molecule into the interior of the cell; a targeting module which directs the MAT molecule to intracellular organelles involved in antigen processing and loading; and an antigen module which contains an allergen
12/22/2005US20050281815 CD40 splice variants and their uses
12/22/2005US20050281812 Antibodies to insulin-like growth factor I receptor
12/22/2005US20050281811 Anti-lymphotoxin-beta receptor antibodies as anti-tumor agents
12/22/2005US20050281810 Variants of alternative splicing
12/22/2005US20050281808 Peptide fragments having cell death-inhibitory activity
12/22/2005US20050281793 T cell activation
12/22/2005US20050281779 Enhancing immune responses to genetic immunization by using a chemokine
12/22/2005US20050281743 Cancer associated protein phosphatases and their uses
12/22/2005US20050281741 Using cyanine dyes; in situ target tumor cells
12/22/2005DE19605657B4 Menschliches Proinsulinderivat, Kodierende DNA, DNA enthaltender Expressionsvektor, mit diesem transformierter Mikroorganismus und Verwendung dieses menschlichen Proinsulinderivats Human proinsulin derivative-encoding DNA, DNA-containing expression vector, transformed with this microorganism and use of this human Proinsulinderivats
12/22/2005DE10344545B4 Genetisch modifiziertes Kapsidprotein des Beak and Feather Disease Virus Genetically modified capsid protein of the Beak and Feather Disease Virus
12/22/2005DE10005932B4 Peptide und deren Verwendung in einem Verfahren zur Diagnostik von Zöliakie und Dermatitis herpetiformis Peptides and their use in a method for the diagnosis of celiac disease and dermatitis herpetiformis
12/22/2005CA2570195A1 Polynucleotides and polypeptides involved in plant fiber development and methods of using same
12/22/2005CA2570043A1 Env polypeptide complexes and methods of use
12/22/2005CA2570033A1 The shine clade of transcription factors and their use
12/22/2005CA2569909A1 Vaccine compositions and methods
12/22/2005CA2569821A1 Process for protein isolation
12/22/2005CA2569788A1 Tumor specific antibody
12/22/2005CA2569662A1 Heparin binding peptide
12/22/2005CA2569142A1 Sars vaccines and methods to produce highly potent antibodies
12/22/2005CA2567877A1 Polynucleotides encoding acetylcholine-gated chloride channel subunits of caenorhabditis elegans
12/22/2005CA2565678A1 Peptide substrates recognisable by a botulinum toxin a, bont/a and the use thereof
12/22/2005CA2565124A1 Peptide capable of altering tubulin polymerization and use thereof for inhibiting cell proliferation
12/22/2005CA2564784A1 Episomal fusion gene
12/22/2005CA2507844A1 Brassica ahas genes and gene alleles that provide resistance to imidazolinone herbicides
12/21/2005EP1607745A2 Ligand for G-protein coupled receptor FPRL2 and uses thereof
12/21/2005EP1607744A2 Treatment of diseases involving cyst formation with combinations comprising a PTBR agonist
12/21/2005EP1607402A1 Method for the diagnosis of tumour
12/21/2005EP1607101A1 Degradation inhibitor for hepatitis b virus x interacting protein
12/21/2005EP1606628A2 Ph-dependent polypeptide aggregation and its use
12/21/2005EP1606418A1 Methods for the diagnosis and treatment of epilepsy
12/21/2005EP1606411A1 Mutant vesicular stomatitis viruses and use thereof
12/21/2005EP1606410A2 Nucleic acid controlling the expression of a useful polypeptide in the posterior silk glands of a lepidoptera and application thereof
12/21/2005EP1606409A2 Nogo receptor binding protein
12/21/2005EP1606408A2 Human p53 splice variant displaying differential transcriptional activity
12/21/2005EP1606402A1 Immunoadsorption of anti-von willebrand factor cleaving protease antibodies
12/21/2005EP1606398A1 Melan-a peptide analogue-virus-like-particle conjugates
12/21/2005EP1606397A1 Adenovirus serotype 24 vectors, nucleic acids and virus produced thereby
12/21/2005EP1606391A2 Virulent systemic feline calicivirus
12/21/2005EP1606319A2 Treatment of viral infections
12/21/2005EP1606318A2 Improved fc fusion proteins
12/21/2005EP1606317A2 Anti-il-22ra antibodies and binding partners and methods of using in inflammation
12/21/2005EP1606316A2 Anti-il-20 antibodies and binding partners and methods of using in inflammation
12/21/2005EP1606313A2 Specific inhibition of allograft rejection
12/21/2005EP1606312A2 Baff mutants with at least one amino acid substitution and methods of their production
12/21/2005EP1606311A1 Interferon-alpha induced gene
12/21/2005EP1606310A2 Secreted protein family
12/21/2005EP1606309A2 Antimicrobial agents from streptococcus mitis and streptococcus oralis
12/21/2005EP1606308A2 Tumour-associated peptides binding to mhc molecules
12/21/2005EP1606305A2 Nucleic acid compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1606297A2 High viscosity xanthan polymer preparations
12/21/2005EP1606232A1 Improved extraction process
12/21/2005EP1606175A1 Lock for a flat and low pourer provided with a removable element in the form of a laminate of film for a composite package for container openings closed by a nonpermeable film
12/21/2005EP1605978A2 Therapeutic compositions
12/21/2005EP1605973A1 Packaging of immunostimulatory oligonucleotides into virus-like particles: method of preparation and use
12/21/2005EP1605972A2 Hiv-peptide-carrier-conjugates
12/21/2005EP1605965A1 Use of saposin-related proteins for preventing and treating obesity, diabetes and/or metabolic syndrome
12/21/2005EP1605964A1 TARGETED PROTEIN DEGRADATION VEHICLES (TPDVs), NUCLEIC ACID CONSTRUCTS ENCODING THEM AND THEIR USE
12/21/2005EP1605961A2 Polypeptide compounds for inhibiting angiogenesis and tumor growth
12/21/2005EP1605897A2 Polyethelene glycol link glp-1 compounds
12/21/2005EP1576086A3 Therapeutic polypeptides, nucleic acids encoding same, and methods of use
1 ... 1110 1111 1112 1113 1114 1115 1116 1117 1118 1119 1120 1121 1122 1123 1124 1125 1126 1127 1128 1129 1130 ... 2916